These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 20130415)

  • 41. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
    Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI
    J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus.
    Stephan C; Berger A; Carlebach A; Lutz T; Bickel M; Klauke S; Staszewski S; Stuermer M
    J Antimicrob Chemother; 2005 Dec; 56(6):1087-93. PubMed ID: 16269552
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
    Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ;
    J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple surface antigen mutations in five blood donors with occult hepatitis B virus infection.
    Zaaijer HL; Torres P; Ontañón A; Ponte LG; Koppelman MH; Lelie PN; Hemert FJ; Boot HJ
    J Med Virol; 2008 Aug; 80(8):1344-9. PubMed ID: 18551607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunocompromised patients with HBsAg a determinant mutants: comparison of HBsAg diagnostic assays.
    Veropalumbo E; Marrone A; Vallefuoco L; Perruolo G; Orlando R; Scordino F; Tosone G; Zampino R; Trani B; Genovese A; Spadaro G; D'Orio C; Portella G
    Intervirology; 2010; 53(3):183-7. PubMed ID: 20197685
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Occult hepatitis B virus infection before and 1 year after start of HAART in HIV type 1-positive patients.
    Pogány K; Zaaijer HL; Prins JM; Wit FW; Lange JM; Beld MG
    AIDS Res Hum Retroviruses; 2005 Nov; 21(11):922-6. PubMed ID: 16386107
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diversity of hepatitis B virus infecting Malaysian candidate blood donors is driven by viral and host factors.
    Meldal BH; Bon AH; Prati D; Ayob Y; Allain JP
    J Viral Hepat; 2011 Feb; 18(2):91-101. PubMed ID: 20196797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular analysis of the hepatitis B virus presurface and surface gene in patients from eastern China with occult hepatitis B.
    Huang X; Qin Y; Li W; Shi Q; Xue Y; Li J; Liu C; Hollinger FB; Shen Q
    J Med Virol; 2013 Jun; 85(6):979-86. PubMed ID: 23588723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Atypical serological profiles in hepatitis B infections: investigation of S gene mutations in cases with concurrently positive for HBsAg and anti-HBs].
    Aydın N; Kırdar S; Uzun N; Eyigör M; Sayan M
    Mikrobiyol Bul; 2016 Oct; 50(4):535-543. PubMed ID: 28124958
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of genotypes C and D of the hepatitis B virus in Japan: a clinical and molecular biological study.
    Duong TN; Horiike N; Michitaka K; Yan C; Mizokami M; Tanaka Y; Jyoko K; Yamamoto K; Miyaoka H; Yamashita Y; Ohno N; Onji M
    J Med Virol; 2004 Apr; 72(4):551-7. PubMed ID: 14981757
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of precore mutants in anti-HBe-positive hepatitis B virus carriers in Germany.
    Knöll A; Rohrhofer A; Kochanowski B; Wurm EM; Jilg W
    J Med Virol; 1999 Sep; 59(1):14-8. PubMed ID: 10440802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
    J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Investigation of the presence of HBV-DNA in isolated anti-HBc positive cases and their importance in blood banking].
    Bal SH; Heper Y; Kumaş LT; Mistik R; Töre O
    Mikrobiyol Bul; 2009 Apr; 43(2):243-50. PubMed ID: 19621609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular epidemiology of hepatitis B virus in Dakar, Sénégal.
    Vray M; Debonne JM; Sire JM; Tran N; Chevalier B; Plantier JC; Fall F; Vernet G; Simon F; Mb PS
    J Med Virol; 2006 Mar; 78(3):329-34. PubMed ID: 16419106
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
    Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
    Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HBsAg-negative mono-infection with hepatitis B virus genotype G.
    Zaaijer HL; Boot HJ; van Swieten P; Koppelman MH; Cuypers HT
    J Viral Hepat; 2011 Nov; 18(11):815-9. PubMed ID: 21114585
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A serological and molecular survey of hepatitis B in children 15 years after inception of the national hepatitis B vaccination program in eastern China.
    Dong Y; Liu SL; Zhai XJ; Zhu FC; Pan H; Yu JX; Chen YZ; Xie YR; Zhang XY; Zhang HM; Li LJ; Wang H; Ruan B
    J Med Virol; 2009 Sep; 81(9):1517-24. PubMed ID: 19626618
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan.
    Toyoda H; Hayashi K; Murakami Y; Honda T; Katano Y; Nakano I; Goto H; Kumada T; Takamatsu J
    J Med Virol; 2004 Jun; 73(2):195-9. PubMed ID: 15122792
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Virological characteristics of occult hepatitis B virus in a North American cohort of human immunodeficiency virus type 1-positive patients on dual active anti-HBV/HIV therapy.
    Coffin CS; Mulrooney-Cousins PM; Osiowy C; van der Meer F; Nishikawa S; Michalak TI; van Marle G; Gill MJ
    J Clin Virol; 2014 Aug; 60(4):347-53. PubMed ID: 24881491
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Occult hepatitis B virus infection in Korean patients with isolated anti-HBc.
    Kang SY; Kim MH; Lee WI
    Arch Virol; 2014 Feb; 159(2):227-33. PubMed ID: 23933720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.